Alva Review-Courier -

Articles written by Lauran Neergaard

Sorted by date  Results 1 - 25 of 143



Strong RSV vaccine data lifts hopes after years of futility

New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall. The preliminary results buoy hope that after decades of failure...

 

US clears updated COVID boosters targeting newest variants

WASHINGTON (AP) — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe...

 

Major test of first possible Lyme vaccine in 20 years begins

DUNCANSVILLE, Pa. (AP) — Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne threat. Lyme is a growing problem,...

 

Study casts more doubt on use of high-dose vitamin D pills

More research suggests it's time to abandon the craze over vitamin D. Taking high doses of "the sunshine vitamin" doesn't reduce the risk of broken bones in generally healthy older Americans, researchers reported Wednesday. It's the latest in a...

 

CDC advisers endorse more traditional Novavax COVID shot

U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, influential government advisers said Tuesday. Regulators authorized the nation's first so-called protein vaccine ag...

 

Pig organ transplants inch closer with testing in the dead

New York researchers transplanted pig hearts into two brain-dead people over the last month, the latest in a string of developments in the long quest to one day save human lives with animal organs. The experiments announced Tuesday come after a...

 

Novel genetic experiment shrinks tough-to-treat cancer

In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells, highlighting a possible new way to someday treat a variety of cancers. Kathy Wilkes...

 

CDC urges Pfizer booster for children ages 5 to 11

Kids ages 5 to 11 should get a booster dose of Pfizer's COVID-19 vaccine, advisers to the U.S. government said Thursday. The Center for Disease Control and Prevention quickly adopted the panel's recommendation, opening a third COVID-19 shot to...

 

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said the shot should only be given to adults who can...

 

Moderna announces step toward updating COVID shots for fall

Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work. Today's COVID-19 vaccines all...

 

US opens second COVID boosters to 50 and up, others at risk

Americans 50 and older can get a second COVID-19 booster if it's been at least four months since their last vaccination, a chance at extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration on...

 

Who really needs a second COVID booster? Here's what to know

Many Americans now can get a second COVID-19 booster, but it's hard to tell who really needs another shot right now and who could wait. The Food and Drug Administration authorized extra Pfizer or Moderna shots for anyone 50 or older and for some...

 

Pfizer asks FDA to allow COVID-19 vaccine for kids under 5

WASHINGTON (AP) — Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. In an...

 

US advisers endorse Pfizer COVID boosters for younger teens

Influential government advisers are strongly urging that teens as young as 12 get COVID-19 boosters as soon as they're eligible, a key move as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike. All...

 

EXPLAINER: Boosters key to fight omicron, lot still to learn

The new omicron variant took only a few weeks to live up to dire predictions about how hugely contagious it is but scientists don't yet know if it causes more severe disease even as the world faces exploding cases just before Christmas. "Everything...

 

US opens COVID boosters to all adults, urges them for 50+

WASHINGTON (AP) — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans...

 

FDA paves way for Pfizer COVID-19 vaccinations in young kids

WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use,...

 

FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received...

 

FDA panel endorses booster shot for J&J COVID-19 vaccine

WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands. J&J told the Food and Drug...

 

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner...

 

US panel backs COVID-19 boosters only for seniors, high-risk

WASHINGTON (AP) — Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those who...

 

CDC finds unvaccinated 11 times more likely to die of COVID

New U.S. studies released Friday show the COVID-19 vaccines remain highly effective against hospitalizations and death even as the extra-contagious delta variant swept the country. One study tracked over 600,000 COVID-19 cases in 13 states from...

 

COVID-19 boosters are coming but who will get them and when?

COVID-19 booster shots may be coming for at least some Americans but already the Biden administration is being forced to scale back expectations — illustrating just how much important science still has to be worked out. The initial plan was to offe...

 

US regulators give full approval to Pfizer COVID-19 vaccine

WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations...

 

Do I need a booster if I got the Johnson & Johnson vaccine?

Do I need a booster if I got the Johnson & Johnson vaccine? Probably at some point, but health officials still are collecting the data needed to decide. With boosters being planned in the U.S. as early as the fall for those who got the two-shot...

 

Page Down

Our Family of Publications Includes:

Arc
Newsgram

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2023